Skip to main content Accessibility help
×
Hostname: page-component-586b7cd67f-dsjbd Total loading time: 0 Render date: 2024-11-23T22:27:23.492Z Has data issue: false hasContentIssue false

Chapter 8 - Mitochondrial Diseases in the Pediatric Kidney

from Section 2 - Glomerular Diseases

Published online by Cambridge University Press:  10 August 2023

Helen Liapis
Affiliation:
Ludwig Maximilian University, Nephrology Center, Munich, Adjunct Professor and Washington University St Louis, Department of Pathology and Immunology, Retired Professor
Get access

Summary

In general, kidney disease is not a very common feature of mitochondriopathies but tends to be more prevalent in children than adults. Overall, the spectrum of kidney disease in a context of multi-organ mitochondrial disease is quite variable, and diagnostic assessment with a kidney biopsy is indispensable to establish the diagnosis. Clinically, most mitochondrial diseases with renal manifestation will cause tubular dysfunction, ranging from renal tubular acidosis to overt Fanconi syndrome (aminoaciduria, hyperuricemia and electrolyte imbalances); rarely, proteinuria and nephrotic syndrome can be a sign. Chronic kidney disease and end-stage kidney disease are the usual outcomes. The two most common mitochondrial diseases that also have renal involvement are Leigh syndrome and mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS) syndrome. Notably, CoQ10 deficiency presents with classic FSGS and proteinuria. Other findings include proximal tubulopathy/granular tubular inclusions (large mitochondria found on EM) which clinically correspond to overt De Toni–Debré–Fanconi syndrome.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2023

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

DiMauro, S., Schon, E. A.. Mitochondrial respiratory-chain diseases. N Engl J Med 2003;348:2656–68.Google Scholar
Luo, S., Valencia, C. A., Zhang, J., et al. Biparental inheritance of mitochondrial DNA in humans. Proc Natl Acad Sci U S A 2018;115:13039–44.Google Scholar
Koenig, M. K.. Presentation and diagnosis of mitochondrial disorders in children. Pediatr Neurol 2008;38:305–13.Google Scholar
Thorburn, D. R.. Mitochondrial disorders: Prevalence, myths and advances. J Inherit Metab Dis 2004;27:349–62.Google Scholar
Stewart, J. B., Chinnery, P. F.. The dynamics of mitochondrial DNA heteroplasmy: Implications for human health and disease. Nat Rev Genet 2015;16:530–42.CrossRefGoogle ScholarPubMed
Rahman, S.. Mitochondrial disease in children. J Intern Med 2020;287:609–33.Google Scholar
Govers, L. P., Toka, H. R., Hariri, A., et al. Mitochondrial DNA mutations in renal disease: An overview. Pediatr Nephrol 2021;36:917.Google Scholar
Schon, E. A., DiMauro, S., Hirano, M.. Human mitochondrial DNA: Roles of inherited and somatic mutations. Nat Rev Genet 2012;13:878–90.Google Scholar
Emma, F., Montini, G., Salviati, L., Dionisi-Vici, C.. Renal mitochondrial cytopathies. Int J Nephrol 2011;2011:609213.Google Scholar
Emma, F., Montini, G., Parikh, S. M., Salviati, L.. Mitochondrial dysfunction in inherited renal disease and acute kidney injury. Nat Rev Nephrol 2016;12:267–80.Google Scholar
O’Toole, J. F.. Renal manifestations of genetic mitochondrial disease. Int J Nephrol Renovasc Dis 2014;7:5767.Google Scholar
Niaudet, P.. Mitochondrial disorders and the kidney. Arch Dis Child 1998;78:387–90.Google Scholar
De Vriese, A. S., Sethi, S., Nath, K. A., et al. Differentiating primary, genetic, and secondary FSGS in adults: A clinicopathologic approach. J Am Soc Nephrol 2018;29:759–74.Google Scholar
Lee, H. N., Eom, S., Kim, S. H., et al. Epilepsy characteristics and clinical outcome in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS). Pediatr Neurol 2016;64:5965.Google Scholar
Di Donato, S.. Multisystem manifestations of mitochondrial disorders. J Neurol 2009;256:693710.Google Scholar
Jansen, J. J., Maassen, J. A., Van Der Woude, F. J., et al. Mutation in mitochondrial tRNALeu(UUR) gene associated with progressive kidney disease. J Am Soc Nephrol 1997;8:1118–24.Google Scholar
Guery, B., Choukroun, G., Noel, L. H., et al. The spectrum of systemic involvement in adults presenting with renal lesion and mitochondrial tRNA(Leu) gene mutation. J Am Soc Nephrol 2003;14:2099–108.Google Scholar
Hirano, M., Konishi, K., Arata, N., et al. Renal complications in a patient with A-to-G mutation of mitochondrial DNA at the 3243 position of leucine tRNA. Intern Med 2002;41:113–18.Google Scholar
Fervenza, F. C., Gavrilova, R. H., Nasr, S. H., et al. CKD due to a novel mitochondrial DNA mutation: A case report. Am J Kidney Dis 2019;73:273–7.Google Scholar
Connor, T. M., Hoer, S., Mallett, A., et al. Mutations in mitochondrial DNA causing tubulointerstitial kidney disease. PLoS Genet 2017;13:e1006620.Google Scholar
Diomedi-Camassei, F., Di Giandomenico, S., Santorelli, F. M., et al. COQ2 nephropathy: A newly described inherited mitochondriopathy with primary renal involvement. J Am Soc Nephrol 2007;18:2773–80.Google Scholar
Emma, F., Salviati, L.. Mitochondrial cytopathies and the kidney. Nephrol Ther 2017;13 Suppl 1:S23–S8.Google Scholar
Hotta, O., Inoue, C. N., Miyabayashi, S., et al. Clinical and pathologic features of focal segmental glomerulosclerosis with mitochondrial tRNALeu(UUR) gene mutation. Kidney Int 2001;59:1236–43.Google Scholar
Starr, M. C., Chang, I. J., Finn, L. S., et al. COQ2 nephropathy: A treatable cause of nephrotic syndrome in children. Pediatr Nephrol 2018;33:1257–61.Google Scholar
Slone, J., Huang, T.. The special considerations of gene therapy for mitochondrial diseases. NPJ Genom Med 2020;5:7.Google Scholar
Torres-Torronteras, J., Cabrera-Perez, R., Vila-Julia, F., et al. Long-term sustained effect of liver-targeted adeno-associated virus gene therapy for mitochondrial neurogastrointestinal encephalomyopathy. Hum Gene Ther 2018;29:708–18.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×